
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Diosmin is a naturally occurring flavone glycoside primarily derived from lemon peels, renowned for its potent vasoprotective effects. It strengthens blood vessels, improves venous tone, and reduces inflammation through specific molecular pathways, notably inhibiting cytokine production.

Reported Benefits (Provisional)
Origin & History

Diosmin is a naturally occurring flavonoid glycoside found predominantly in lemons (Citrus limon) and other citrus fruits, particularly in their peels. This bioactive compound is recognized for its potent vascular-strengthening and anti-inflammatory properties. It plays a significant role in promoting circulatory health, reducing venous insufficiency, and supporting overall cardiovascular wellness.
Research Narrative (Provisional)
Extensive clinical research, including numerous randomized controlled trials (RCTs) and meta-analyses, strongly supports diosmin's efficacy in treating chronic venous insufficiency (CVI) and hemorrhoids. Studies consistently demonstrate its ability to improve venous tone, reduce inflammation, and alleviate associated symptoms, establishing it as a well-validated compound for vascular health.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Flavonoid Glycoside: A specific class of plant secondary metabolites, with diosmin being the primary bioactive compound. - Vascular Bioactive: Directly impacts venous tone and capillary resistance, crucial for circulatory health. - Antioxidant: Neutralizes free radicals, protecting cellular integrity. - Anti-inflammatory: Modulates inflammatory pathways to reduce systemic inflammation.
Reported Mechanism (Provisional)
Diosmin primarily acts through its anti-inflammatory, anti-thrombotic, and vasoprotective properties. It inhibits the production of pro-inflammatory cytokines such as IL-1 and IL-33, and reduces glial cell activation. Additionally, it stimulates endothelial growth via CEP350 targeting and has shown disruption of PI3K–Akt–MDM2 pathways in cancer models.
Clinical Narrative (Provisional)
Extensive clinical research, including numerous randomized controlled trials (RCTs) and meta-analyses, strongly supports diosmin's efficacy in treating chronic venous insufficiency (CVI) and hemorrhoids. Studies consistently demonstrate its ability to improve venous tone, reduce inflammation, and alleviate associated symptoms. Its effectiveness for CVI is often enhanced when combined with hesperidin. Furthermore, preliminary studies in diabetes models suggest diosmin can dose-dependently lower plasma glucose.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







